Creative Enzymes Launches Plant Extracts for Multiple Applications
Creative Enzymes Launches Plant Extracts for Multiple Applications
As an excellent supplier and manufacturer located in New York, Creative Enzymes has recently introduced the high-quality plant extracts products. With more than ten years of experience in offering professional and high-quality products for academic use and pharmaceutical industries, Creative Enzymes is able to offer the remarkable plant extracts for researchers.
Plant extracts refer to substances extracted or processed from plants (all or a part of plants) using appropriate solvents or methods. They can be used in the pharmaceutical industry, food industry, daily chemical industry and other industries. Creative Enzymes specializes in the research and development and production of natural plant extracts. The company has many years of experience in identification, research, development and production of botanical medicinal active ingredients, focusing on providing innovative products and innovative services to customers in the pharmaceutical, health food and cosmetic industries.
“Creative Enzymes’s plant extracts contain a lot of plant active substances, such as proteins, polysaccharides, flavonoids, anthocyanins, vitamin terpenes and phenolic compounds. Our company has a variety of innovative plant extraction technologies. We will select the appropriate plant extraction process for each raw material and evaluate which solvents and technologies can be used to extract precious plant components.” Commented Vice President of Creative Enzymes.
Creative Enzymes selects more effective plant extraction technology by subdividing all combination parameters (solvent, temperature, extraction time, target active substance, plant tissue, particle size), and can also adjust its process according to customer needs. Its plant extract product line including Phellinus Linteus Extract, Compound coffee powder, Sophora Japonica Extract (Rutin), Pitcher plant extract powder, Wattle seed extract, Lilly pilly fruit extract, Amla Fruit Powder, Tamarind Extract, etc.
At present, the quality of plant extracts on the market is uneven, causing great distress to consumers. Creative Enzymes strictly controls the quality of products and provides customers with a variety of quality reports, so that customers can understand the quality of the products they use. Through the current detection technology, using DNA, HPTLC, HPLC, HPLC-MS to establish the corresponding fingerprint library of plants and related extracts. Studying the changes of plant fingerprints from raw materials to extracts can quickly screen and evaluate the quality of products in the existing market.
“Our company walks in the forefront of the times, industries and markets. With the continuous improvement of the energy efficiency of the current manufacturing process and the increasingly friendly environment, Creative Enzymes has gradually turned to more ecological plant extraction technology without compromising the quality, safety and efficacy of any products.” Said the product manager of Creative Enzymes.
About Creative Enzymes
Creative Enzymes is a remarkable supplier and manufacturer in the Enzymology field. Equipped with advanced technique platform, Creative Enzymes is able to offer high-quality and professional services for customers. Its products and services are widely used in the academic and pharmaceutical industries.
-
Most popular related searches
Related news
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Making Melbourne the world’s best student city
Free tickets to attractions and experiences, dedicated health support services and support for a week-long celebration at Fed Square were among the initiatives endorsed by Council at Tuesday’s meeting. Last month, there were about 70,000 international students in Melbourne – a 53.5 per cent decrease on March 2019. Lord Mayor Sally Capp said creating opportunities for students to discover and enjoy Melbourne will be key to welcoming them back in 2022 and beyond. “We know international...
-
Bold target for Christmas giving campaign
The annual campaign raises awareness and funds for charities, not-for-profits and projects that assist people experiencing homelessness across the municipality, including rough sleepers. The 2021 Good Giving Christmas campaign will support: Primary health and social service Youth Projects, which provides free access to health and social care to improve the wellbeing of people who are, or at risk of, experiencing homelessness. Justice Connect’s Women’s Homelessness Prevention Project, providing...
-
New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction
New Phase III study VICTOR will assess vericiguat efficacy and safety in patients who have not had a recent worsening heart failure event / VICTOR expands upon the Phase III VICTORIA study, providing further insight into the use of vericiguat in a broader range of patients with chronic heart failure with reduced ejection fraction Bayer and its development partner MSD (a tradename of Merck & Co., Inc., Kenilworth, NJ, USA) today announced the start of VICTOR (VerICiguaT in adults with ChrOnic heart failure...
-
European Patent Office maintained Bayer patent on the once-daily administration of rivaroxaban (Xarelto)
The European Patent Office has reversed a first instance decision and maintained a Bayer patent (EP 1 845 961) on the once-daily administration of rivaroxaban (Xarelto™; 10, 15 and 20 mg). The 2.5 mg dose is not affected. Several generic drug manufacturers had initially successfully opposed the patent. With this decision of the European Patent Office, this patent is still valid until mid-January 2026, therefore almost two years longer than the extended compound patent protection until early April 2024....
Customer comments
No comments were found for Creative Enzymes Launches Plant Extracts for Multiple Applications. Be the first to comment!